NCT02890290View on ClinicalTrials.gov

Effect Study of Marine Protein Hydrolysates to Prevent Loss of Muscle Mass and Physical Function in Frail Elderly

NACompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Sarcopenia
Interventions
DIETARY_SUPPLEMENT

Marine Protein hydrolysate

The participants will take the supplement in form of tablets and will be instructed to take five tablets twice a day, preferably in relation to meals, however, not the dinner meal. Each tablet contains 300 mg of marine protein hydrolysates (Nx6.25). The tablets are produced by Flexipharma AS.

DIETARY_SUPPLEMENT

Placebo

Placebo tablets will be made based on gum arabicum. The tablets are produced by Flexipharma AS.

All Listed Sponsors
lead

Molde University College

OTHER

NCT02890290 - Effect Study of Marine Protein Hydrolysates to Prevent Loss of Muscle Mass and Physical Function in Frail Elderly | Biotech Hunter | Biotech Hunter